Latest Thiazolidinedione Stories

PITTSBURGH, Oct. 23, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has filed an expedited motion in the U.S. District Court for the District of Columbia to stay the Court's order related to Watson's abbreviated new drug application (ANDA) for pioglitazone, pending appeal. The U.S. Food and Drug Administration (FDA) joined Mylan in its motion. Mylan CEO Heather Bresch commented, "Mylan is disappointed in yesterday's ruling regarding pioglitazone and we...

Discovery of new biological pathway may help scientists redesign certain diabetes drugs to eliminate or reduce adverse side effects Many drugs work by "fixing" a particular biological pathway that's gone awry in a disease. But sometimes drugs affect other pathways too, producing undesirable side effects that can be severe enough to outweigh the drug's benefits. Such is the case for the thiazolidinedione drugs (also known as TZDs), which are used to treat type 2 diabetes. These are...

The Consumer Justice Foundation, a for-profit corporation whose team of consumer advocates provides free online educational resources to individuals regarding the potential dangers of using certain prescription medications, has a Web site URL that is located at http://www.sideeffectsrx.com. The CJF hereby alerts the pubic of a recent article published in Consumer Reports magazine that advises individuals with diabetes to avoid using Actos or generic equivalents because of concerns...

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved the first generic version of the prescription drug Actos, which is used by adults with type 2 diabetes to help control blood glucose levels. The FDA granted a license to produce generic Actos, also know pioglitazone, to Morgantown, West Virginia-based Mylan Pharmaceuticals, HealthDay News reported on Friday. They will produce the medication in 15mg, 30mg, and 45mg strengths....

The U.S. Food & Drug Administration (FDA) Warned in June 2011 that Taking Actos for More than One Year May Increase Bladder Cancer Risks by as Much as 40%. Since then, Studies Published in the British Medical Journal and the Canadian Medical Association Journal Have Confirmed that Patients who Take Actos Over a Long Period of Time are More Likely to Develop Bladder Cancer. New York, New York (PRWEB) July 30, 2012 Public Health Watchdog, a media outlet created to inform the public...

PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) presented Phase 2b results for MSDC-0160 today at the 72nd Scientific Sessions of the American Diabetes Association. The data showed this novel once-a-day oral insulin sensitizer, the first in a new class of therapeutic agents called mTOT Modulators(TM), met the study's primary endpoint of significantly reducing fasting plasma glucose (FPG) in patients diagnosed with type 2 diabetes, and...

DEERFIELD, Ill. and OSAKA, Japan, April 25, 2012 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. today announced that the company received a complete response letter from the United States (U.S.) Food and Drug Administration (FDA) regarding New Drug Applications (NDAs) for alogliptin and fixed-dose combination (FDC) alogliptin and pioglitazone. Recently, Takeda provided...

CRESSKILL, N.J., Feb. 28, 2012 /PRNewswire/ -- In January 2012, GlaxoSmithKline ("GSK") the United Kingdom's largest pharmaceutical company agreed to resolve more than 20,000 cases alleging their diabetes drug Avandia causes heart attacks. Meanwhile, the plaintiffs' attorneys have not been compensated for their out-of-pocket expenses incurred in pursuing these meritorious cases. RD Legal Funding, LLC ("RD Legal") a leading lawsuit settlement funding company, is available to provide...

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.sideeffectsrx.com, is staffed by a team of professional consumer advocates who provide free online informational resources that help the public become aware of the risks involved with certain prescription medications. The CJF hereby alerts the public of a report published by the CBC that states that a class action Actos side effects lawsuit has been filed in the Ontario Superior Court of...

Study reveals a natural fatty acid used in manufacturing can modulate glucose control A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment. According to the U.S. Center for Disease Control and Prevention (CDC), nearly 26 million Americans have diabetes, and...